Evergreening lets drug companies extend patents on old medications through minor tweaks, blocking cheaper generics and keeping prices high. Learn how it works, who does it, and what it means for patients.
Specialists often choose brand-name specialty drugs over cheaper alternatives not out of preference, but because of real-world risks, inconsistent patient support, and a broken pricing system that makes generics more expensive than they should be.